95 related articles for article (PubMed ID: 6106885)
1. [Lowering the heart rate in tachycardiac atrial fibrillation by beta receptor blockade].
Horn HG; Neuss H; Schlepper M; Mitrovic V; Stämmler G
Med Klin; 1980 Sep; 75(20):721-5. PubMed ID: 6106885
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent.
Klein G; Wirtzfeld A; Alt E; Steck J; Saunders R; Hulse J; Kartzinel R; Lee R; Laddu AR
Int J Clin Pharmacol Ther Toxicol; 1984 Feb; 22(2):112-7. PubMed ID: 6142005
[TBL] [Abstract][Full Text] [Related]
3. Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
DiBianco R; Morganroth J; Freitag JA; Ronan JA; Lindgren KM; Donohue DJ; Larca LJ; Chadda KD; Olukotun AY
Am Heart J; 1984 Oct; 108(4 Pt 2):1121-7. PubMed ID: 6148872
[TBL] [Abstract][Full Text] [Related]
4. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
[TBL] [Abstract][Full Text] [Related]
5. [The effect of the beta-blocker nadolol on the second messenger, serum cyclic adenosine monophosphate, and on blood pressure and heart rate].
Weth G; Schneider J; Rodatz H; Haubitz I
Arzneimittelforschung; 1985; 35(11):1711-3. PubMed ID: 2868733
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol.
Coumel P; Escoubet B; Attuel P
Am Heart J; 1984 Oct; 108(4 Pt 2):1098-108. PubMed ID: 6148870
[TBL] [Abstract][Full Text] [Related]
7. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
Vavrejnová V; Felt V; Nedvídková J
Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
[No Abstract] [Full Text] [Related]
8. [Field trial with a new betablocker (Solgol)].
Piergies A; Schimert G
MMW Munch Med Wochenschr; 1980 Oct; 122(42):1473-6. PubMed ID: 6110182
[TBL] [Abstract][Full Text] [Related]
9. Initial therapy of essential hypertension: diuretic or beta blocker?
Finnerty FA
J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
Blagova OV; Nedostup AV
Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
[TBL] [Abstract][Full Text] [Related]
11. [Heart rate reduction in atrial fibrillation with a rapid ventricular response by Gallopamil, a Ca-antagonist (author's transl)].
Neuss H; Horn HG; Mitrović V; Buss J; Schlepper M
Z Kardiol; 1982 May; 71(5):334-9. PubMed ID: 7113326
[TBL] [Abstract][Full Text] [Related]
12. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
13. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
O'Callaghan EG
Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
[No Abstract] [Full Text] [Related]
14. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
Mooss AN; Wurdeman RL; Mohiuddin SM; Reyes AP; Sugimoto JT; Scott W; Hilleman DE; Seyedroudbari A
Am Heart J; 2000 Jul; 140(1):176-80. PubMed ID: 10874282
[TBL] [Abstract][Full Text] [Related]
15. Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmias.
Nademanee K; Schleman MM; Singh BN; Morganroth J; Reid PR; Stritar JA
Am Heart J; 1984 Oct; 108(4 Pt 2):1109-15. PubMed ID: 6207720
[TBL] [Abstract][Full Text] [Related]
16. [Mitral valve prolapse. Evaluation of the efficacy of nadolol on the control of clinical symptoms and on the normalization of electrocardiographic tracings].
Bichuette HS
Arq Bras Cardiol; 1984 Dec; 43(6):449-56. PubMed ID: 6152676
[No Abstract] [Full Text] [Related]
17. Peripheral beta-adrenergic blockade treatment of parkinsonian tremor.
Foster NL; Newman RP; LeWitt PA; Gillespie MM; Larsen TA; Chase TN
Ann Neurol; 1984 Oct; 16(4):505-8. PubMed ID: 6149724
[TBL] [Abstract][Full Text] [Related]
18. [Drug treatment of a trial fibrillation in patients with Wolff-Parkinson-White syndrome].
Guaragna RF; Capucci A; Sangiorgio P; Bracchetti D
G Ital Cardiol; 1982; 12(4):284-91. PubMed ID: 6130024
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
[TBL] [Abstract][Full Text] [Related]
20. Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent.
David D; Segni ED; Klein HO; Kaplinsky E
Am J Cardiol; 1979 Dec; 44(7):1378-82. PubMed ID: 41449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
